Telemetry Investments’s Xtant Medical Holdings XTNT Stock Holding History

Telemetry Investments’s Portfolio XTNT Stock Details XTNT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-146,139	Closed	-$120K	–	95
2020 Q3	$120K	Sell	146,139 -59,427	-29%	-$58.2K	0.26%	64
2020 Q2	$185K	Sell	205,566 -547,068	-73%	-$502K	0.5%	54
2020 Q1	$504K	Sell	752,634 -281	-0%	-$339	1.76%	28
2019 Q4	$1.21M	Sell	752,915 -18,621	-2%	-$38.2K	4.02%	8
2019 Q3	$2.19M	Sell	771,536 -10,818	-1%	-$30.1K	6.32%	4
2019 Q2	$2.35M	Buy	782,354 +13,441	+2%	+$41.3K	1.81%	10
2019 Q1	$2.35M	Sell	768,913 -27,913	-4%	-$81.3K	1.19%	15
2018 Q4	$1.28M	Buy	796,826 +63,079	+9%	+$203K	0.82%	31
2018 Q3	$2.83M	Buy	+733,747	New	+$3.88M	1.28%	18

Other funds holding XTNT

OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Bruce & Co Chicago, Illinois $369M AUM 50.95% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $5.69B AUM 60.64% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return

Telemetry Investments's XTNT Position: Q4 2020 in Review

Telemetry Investments sold out of Xtant Medical Holdings (XTNT) in Q4 2020, closing a stake of 146,139 shares — an estimated $120K sold.

Telemetry Investments first reported a position in XTNT in Q3 2018 and held it in 9 quarters. The position peaked at $2.83M in Q3 2018. 20 funds tracked by Wall St. Rank hold XTNT as of Q4 2020.

Telemetry Investments reported no remaining Xtant Medical Holdings position as of Q4 2020 after selling out during the quarter.
Telemetry Investments sold 146,139 Xtant Medical Holdings shares in Q4 2020, an estimated $120K.
Telemetry Investments first reported a position in Xtant Medical Holdings in Q3 2018 and held it in 9 quarters.
Telemetry Investments's Xtant Medical Holdings position peaked at $2.83M in Q3 2018.
20 funds tracked by Wall St. Rank held Xtant Medical Holdings as of Q4 2020.

Based on Telemetry Investments's 13F filing for Q4 2020, filed 16 Feb 2021.